Chest Infections

On this page

RESOURCES

Clinician education resources

NEWS

News and notes


Advertisement


Bridging Specialties®: Timely Diagnosis for NTM Pulmonary Disease and Bronchiectasis displayed on a laptop screen.

Bridging Specialties®: Timely Diagnosis for NTM Pulmonary Disease and Bronchiectasis

Nontuberculous mycobacterial (NTM) pulmonary disease and bronchiectasis are complex, often underrecognized lung conditions that can mimic more common respiratory diseases, such as chronic bronchitis or TB. This can lead to delays in diagnosis and treatment.

The new Bridging Specialties: Timely Diagnosis for NTM Pulmonary Disease and Bronchiectasis program offers tools to help pulmonologists, primary care physicians, and advanced practice providers improve the time to diagnosis and treatment for patients with NTM pulmonary disease and bronchiectasis.

Access on-demand webinars and podcasts, plus stay tuned for a clinician toolkit coming soon.

Sponsored by Insmed Incorporated.

ACCESS PROGRAM »

Bridging Specialties®: Timely Diagnosis for NTM Pulmonary Disease and Bronchiectasis displayed on a laptop screen.

Join the Chest Infections and Disaster Response Network

CHEST Networks are specialty-focused communities that provide forums for leadership, education, and advocacy. The Chest Infections and Disaster Response Network serves as the main resource and forum for issues related to pulmonary infections, as well as disaster response and global health.

LEARN MORE »

Chest infections news and notes

Follow the latest chest infections news

CHEST INFECTIONS SECTION

Aspergillus in Bronchiectasis: An Expanding Spectrum of Disease and Diagnostic Challenge
Recent findings underscore the need to integrate Aspergillus serologies into routine bronchiectasis care and adopt a phenotype-driven, personalized approach to fungal surveillance and treatment.

DISASTER RESPONSE AND GLOBAL HEALTH SECTION

Medical Preparedness and Critical Care for the 2026 FIFA World Cup
In 2026, the FIFA World Cup will be hosted in North America and will test the continent's health care infrastructure.

PULMONARY PERSPECTIVES®

Pseudomonas Infection in Patients with Noncystic Fibrosis Bronchiectasis
The Pseudomonas infection is leading to increased hospitalizations and current antibiotic regimens are struggling to acheive eradication.

CHEST PHYSICIAN®

Brensocatib Awaits FDA Approval for Bronchiectasis Following ASPEN Results
Experts discuss the potential clinical implications of addressing inflammation in bronchiectasis—from reduced exacerbations and slowed decline in FEV to improved quality of life.

EHR Data Confirm Effectiveness of RSV Vaccine in Adults Aged 60 and Older
Results aligned with those from the clinical trials done before FDA approval. The study demonstrated the value of using real-time electronic health records to address public health questions quickly.

BLOG

Approaching Multidrug-Resistant TB With Shorter and Better Tolerated Oral Drug Regimens
MDR-TB poses a global challenge, but newer all-oral regimens like BPaL offer safer, more effective treatment.

Build your chest infections expertise

CHEST SEEK® Education

Written and peer reviewed by renowned experts in the critical care, pulmonary, and sleep medicine fields, the online CHEST SEEK Library and print publications include case-based questions and detailed rationales to stimulate and challenge your clinical thought process; help you prepare for certification or recertification exams; and allow you to obtain CME credit, MOC points, and CE hours.


CHEST SEEK LIBRARY

Access hundreds of critical care, pulmonary, and sleep medicine questions.

PURCHASE NOW »

Join the community

If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities.

JOIN NOW »